Lessons from the failure of some of India's biggest business names.

He was taken to the hospital after he complained of uneasiness and breathlessness because of a chest infection.

The development is a hugely positive development both for Sun Pharma and for Indian pharma. From a sentiment perspective, it is significant given that the company has been finally able to get its facility cleared after three years.

Just prior to the results, on May 23, Sun Pharma had announced that the US drug regulator USFDA (US Food and Drug Administration) approved Yonsa, its drug to treat a kind of prostate cancer.

India is making new records in road construction. This makes some companies good investments.

Amid the global clash between Saudi - led OPEC & US shale oil producers, India is crafting a balanced strategy to minimise the economic shocks of rising oil prices.

With USD 8.8 billion, Savitri Jindal is the richest Indian woman on the list.

Unitech is facing huge protest from home buyers because of delay in completion of about 70 projects. Earlier this week, the Supreme Court stayed NCLT order allowing the Centre to take over the management of Unitech.

Pharma stocks continue to underperform as policy uncertainty adds to the toll taken by USFDA and market challenges.

There was an increase of 26 per cent in the aggregate wealth of the top 100 richest people.

Commuters chewing pan masala were asked to spit it before entering the station.

On August 3rd, the largest generic company operating in the US, Teva Pharmaceutical Industries (Teva in quickspeak) put out results that arguably jolted the world of global generic medicines.

A motley group of emerging infrastructure companies has seen rapid growth in recent years.

Headed by Kumar Mangalam Birla, the group's outfit Aditya Birla Nuvo had set up a 51:49 joint venture-Aditya Birla Idea Payments Bank-with telecom major Idea Cellular to launch payments bank services in the country.

India has embarked on the world's biggest skill development programme. Can this bridge the talent gap?